NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
10.69 USD
+0.03 (+0.28%)
10.69 USD
0 (0%)
NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. While NUS has a great health rating, its profitability is only average at the moment. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
Of the past 5 years NUS 4 years were profitable.
NUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 6.98%, NUS is doing good in the industry, outperforming 69.44% of the companies in the same industry.
NUS has a Return On Equity of 12.80%. This is amongst the best in the industry. NUS outperforms 80.56% of its industry peers.
The Return On Invested Capital of NUS (3.88%) is comparable to the rest of the industry.
NUS had an Average Return On Invested Capital over the past 3 years of 5.22%. This is significantly below the industry average of 12.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
The Profit Margin of NUS (6.20%) is better than 72.22% of its industry peers.
NUS's Operating Margin of 3.51% is in line compared to the rest of the industry. NUS outperforms 50.00% of its industry peers.
NUS's Operating Margin has declined in the last couple of years.
NUS's Gross Margin of 67.23% is in line compared to the rest of the industry. NUS outperforms 52.78% of its industry peers.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
The number of shares outstanding for NUS has been increased compared to 1 year ago.
NUS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
NUS has an Altman-Z score of 3.76. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
NUS has a better Altman-Z score (3.76) than 66.67% of its industry peers.
The Debt to FCF ratio of NUS is 0.61, which is an excellent value as it means it would take NUS, only 0.61 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NUS (0.61) is better than 91.67% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that NUS is not too dependend on debt financing.
NUS's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. NUS outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.76 |
ROIC/WACC0.52
WACC7.47%
2.3 Liquidity
NUS has a Current Ratio of 2.01. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
NUS has a Current ratio (2.01) which is comparable to the rest of the industry.
A Quick Ratio of 1.38 indicates that NUS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, NUS is in line with its industry, outperforming 58.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The earnings per share for NUS have decreased by -1.63% in the last year.
The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -11.80% in the last year.
The Revenue has been decreasing by -6.47% on average over the past years.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
Based on estimates for the next years, NUS will show a very strong growth in Earnings Per Share. The EPS will grow by 36.15% on average per year.
Based on estimates for the next years, NUS will show a decrease in Revenue. The Revenue will decrease by -5.71% on average per year.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.83, the valuation of NUS can be described as very reasonable.
NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 91.67% of the companies in the same industry.
NUS is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.78, the valuation of NUS can be described as very cheap.
91.67% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.83 | ||
| Fwd PE | 6.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.67% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.29 | ||
| EV/EBITDA | 4.33 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUS's earnings are expected to grow with 36.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.25%, NUS has a reasonable but not impressive dividend return.
NUS's Dividend Yield is a higher than the industry average which is at 5.90.
Compared to an average S&P500 Dividend Yield of 2.36, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
11.83% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
10.69
+0.03 (+0.28%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change-0.1%
Ins Owners2.08%
Ins Owner Change3.24%
Market Cap529.15M
Analysts45
Price Target7.65 (-28.44%)
Short Float %4.62%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.83 | ||
| Fwd PE | 6.78 | ||
| P/S | 0.33 | ||
| P/FCF | 1.29 | ||
| P/OCF | 1.19 | ||
| P/B | 0.67 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | 4.33 |
EPS(TTM)1.21
EY11.32%
EPS(NY)1.58
Fwd EY14.74%
FCF(TTM)8.3
FCFY77.66%
OCF(TTM)9
OCFY84.23%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.18
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexcg growth 3Y-45.58%
ROICexcg growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.76 |
F-Score6
WACC7.47%
ROIC/WACC0.52
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%